Myeloma UK Survivorship grant call

Our latest research grant call is a unique opportunity to improve the care experience for people affected by myeloma and enhance their ongoing quality of life during diagnosis, treatment, and assessment.

We are actively seeking research applications focused on survivorship in myeloma care. 

The aim is to make a meaningful impact on the patient journey, whether through identifying non-invasive assessment procedures, enhancing the patient experience during procedures like bone aspiration, reducing treatment side effects, or improving patient-led condition management. 

We also welcome applications testing pilot schemes and new technologies.

Who can apply?

The grant call is open to all healthcare professionals who work with myeloma patients, including allied health professionals and nurses. 

We are particularly interested in applications that have an immediate and demonstrable impact on the patient clinical journey. We are not seeking ‘basic science’ or ‘translational research’ applications as part of this grant call. 

Patient-Public Involvement (PPI)

Patient-Public Involvement (PPI) must form an integral and key part of all applications submitted. Creative and innovative approaches to involving patients and families living with myeloma are of particular interest. 

As part of the PPI element, we are asking that all applicants ensure the key five principles (below) are included:

  • Equality, diversity and inclusion must form a core part of the PPI element, with special consideration given on how underserved communities will be included
  • Evidence for ongoing involvement of PPI throughout the project, inclusive of the research questions, grant application, continuing throughout the research programme, during dissemination and if necessary, beyond the timeline of the project. Demonstrating how you will measure the impact of PPI throughout the course of the project is encouraged
  • Applicants should demonstrate and define how they will deliver high quality PPI (i.e. aligned to the NIHR UK Standards for Patent and Public Involvement)
  • It is expected that applicants will provide PPI members (patients and carers) with an opportunity to showcase their involvement in the project and to develop their skills where appropriate (i.e. through local dissemination, at UK meetings/conferences, in publications)
  • Applicants must consider having a patient/carer on the grant as a co-applicant/investigator to support key project deliverables. This may involve recruitment to the research, other relevant local/national activities, and supporting the delivery of equity, diversity and inclusion into the project. If included, please state their role in the project and clearly outline what they would do during the project and justification for their activities

Key grant call details 

  • Call opens: 4 October 2023
  • Call closes: 1 April 2024 at 5pm
  • Maximum funding available: £170,000

How to apply

To apply for the grant, review the guidance for applicants and send your completed application form to by 5pm on 1 April 2024.

If you’d like to discuss your potential application during the open call period, you can contact our Interim Research Manager, Dr Fatima Sulaiman, on

Close-up photograph of a hand holding a mobile phone.

Stay in touch

We’d love to stay in touch. Join our mailing list to receive updates from Myeloma UK including our monthly newsletter and updates about our services, research, campaigns and other ways you can get involved.